본문
RadianQbio, receives total investment of 6.5 billion Won from Neoplux and others
RadianQbio, receives another 3.5 billion Won investment from Neoplux and others, makes total investment of 6.5 billion Won
RadianQbio has received another 3.5 billion Won investment following to 3 billion Won investment received in 2017.
On 21st, RadianQbio reported that they have received 3.5 billion Won investment from Neoplux, IBK Investment Securities and KDB Capital recently. Total investment received has increased to 6.5 billion Won including 3 billion Won investment from KDB Infra last year.
This time’s 3.5 billion investment took place in investors acquiring redeemable convertible preference shares (RCPS) method, and 1.5 billion investment each of redeemable convertible preference shares and convertible bond (CB) was invested from KDB Infra.
RadianQbio is planning to use investment in constructing pilot line for manufacturing bio diagnosis device. Early this year, RadianQbio has completed registration for 12 items to US Food and Drug Administration (FDA). Furthermore, Cooperative Research and Development Agreement (CRADA) with US government agency is coming up shortly.
RadianQbio will participate to US tender late this year expecting export sales. Sales in domestic Korean market is expected in early next year after cooperative clinical trial with Guro Korea University Hospital and acquisition of Korea Food and Drug Administration (KFDA) certificate.
RadianQbio explained the medical kit self-developed by company separated over 99 percent of white blood cell out of the whole blood and protein extraction performance has improved more than double compared existing centrifuges in labs and hospitals. With its portability and convenience comes from quarter of credit card sized size, it is expected to help a lot in earlier infectious disease diagnosis, incubation period distinction and also for infants.
Kim Beom Ki, CEO of RadianQbio explained “Medical kit developed by RadianQbio can simply separate white blood cell and provide accurate diagnosis in war, emergency situations and in undeveloped countries since it does not require electric power supply”, and “US government agency is cooperating with us with huge interest on our medical kit”.
